Is Glucose Intolerance a Precursor of Cachexia in Patients With Liver Cirrhosis?

Documenti analoghi

• Steatotic Liver Disease and the “Point of No Return” in the Development of Metabolic Disorders
  di: Tsutomu Nishida, et al.
  Pubblicazione: (2026)
• Refining the predictive utility of aspartate aminotransferase to platelet ratio index in nonalcoholic fatty liver disease patients with COVID‐19
  di: Kengo Matsumoto, et al.
  Pubblicazione: (2024)
• Cachexia and Type 2 Diabetes Mellitus Are Independent Factors for Mortality in Patients With Cirrhosis
  di: Takao Miwa, et al.
  Pubblicazione: (2025)
• Applying Cachexia Criteria to Cirrhosis: Considerations for Appropriate Interpretation and Future Research
  di: Atsushi Nakamura
  Pubblicazione: (2025)
• Cachexia in Cirrhosis Is Characterized by Sex‐Specific Loss of Muscle Mass and Adipose Tissue
  di: Takao Miwa, et al.
  Pubblicazione: (2025)